Changes are on the way for COVID vaccines after the FDA adjusted the standard of evidence needed to approve shots for the general public.

World Health Organization member countries on Tuesday approved an agreement to better prevent, prepare for and respond to ...

They could cost up CA$ 75 to 200. Which is roughly up to $145 in U.S. currency.

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...

Healthy adults younger than 65 will no longer be eligible for COVID-19 shots starting in the fall, according to new federal guidelines announced Tuesday. Vaccine manufacturers seeking approval for ...

Dr. Susan Girois hosted the conversation discussing several topics relating to vaccines, including how they are developed and tested.

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

Under a new policy announced Tuesday by the Trump administration, only people age 65 and older and children or young adults ...

The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk, ...

The FDA announces changes for who's eligible for the COVID-19 vaccine. Plus, should musicians shut up & sing or tell critics ...